Panacea Biotec Limited

NSE:PANACEABIO.NS

359.15 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income -11.712814,488.08-1,450.3-1,773.44462.25-661.39-567.2-189.3-1,065.1-1,109.6-2,530.6-2,553.21,554.91,127.708-866.6641,876.8582,118.557986.842418.042
Depreciation & Amortization 367.1391.2436.61460.74441.35550.32585.33677733.2672.3711860526.1758.9658.78762.179465.882376.192186.524166.112
Deferred Income Tax 00000000000000000000
Stock Based Compensation 00000000000000000000
Change In Working Capital 102.2-3,379.23,015.3219.08-974.961,273.21214.48170.1-582.6-272.81,134.1678.42,878.3-1,221.842.35-1,765.456-1,260.523-125.032427.357-254.282
Accounts Receivables 29.668.94-463.4-168.57201.14347.35-203.67-255.2-412.8-48.3-406.4-47.100000000
Inventory 241.6106.3-385.8-264.45-662.64847.63-188.32-6.649.9352.4481.21,173.2253.7874.9-63.68-2,367.284-53.828-274.798116.41-141.614
Accounts Payables 000235.08-496.8975.06312.74628.72-21000000000000
Other Working Capital -169-3,554.443,864.5417.02-16.573.17402.8176.7-632.5-625.2652.9-494.82,624.6-2,096.7106.03601.828-1,206.695149.767310.946-112.668
Other Non Cash Items 62.5-1,374.6-19,024.341,838.122,002.35-1,2371,041.81866.7945.61,037.9-136.3752.11,429.7-190.3-1,207.1291,801.57-414.084-799.798-1.818-32.13
Operating Cash Flow 57.1-4,234.6-1,084.351,067.64-304.71,048.781,180.231,146.6906.9372.3599.2-240.12,280.9901.7621.709-68.372668.1331,569.921,598.905297.742
Investing Activities:
Investments In Property Plant And Equipment -777.2-409.5-125.1-217.63-69.11-47.83-152.16-328.4-113.2-78.3-559.8-797.9-1,344.8-499.2-1,220.406-2,025.134-2,926.139-2,218.729-1,166.16-525.043
Acquisitions Net 66.8-4,202.0718,22055.9452.21-0.82723.07-230.557.30000-73.3000000
Purchases Of Investments -3,472.5-8,675.6-10,493.6-391.93-452.93-37.74-38.73-9.9-20.7-332.2-17.800-0.3-4.425-762.111-1,403.535-403.06200
Sales Maturities Of Investments 4,201.412,877.75,171.63336.030.7220.2922.0813.8222.800117.747.8167.901,400.077402.064,171.04402.178
Other Investing Activites 879.54,712.7752.8-259.16-278.4912.58-1.32246.775.536.8139.768.257.9206.653.021234.41889.078174.9250.50433.219
Investing Cash Flow 18.54,303.312,825.73-476.79-347.6-53.52552.94-308.3164.4-373.7-437.9-612-1,239.1-198.3-1,171.81-1,152.75-3,838.5361,724.173-1,115.655-489.646
Financing Activities:
Debt Repayment -2.4-147.8-7,863.64-489.14-6,392.07-347.5-646.43-818.5-1,218.3-813.4-143.1-2,581.9-2,184.1-188.8-327.663-436.3530-138.438-103.728-261.785
Common Stock Issued 0000320000337.810002,919.929.91100-101.6870224.974
Common Stock Repurchased 0000000000000-1,098.3-31.80500-904.3490-53.465
Dividends Paid 000000000000-53.4-15.6-0.039-81.15-76.873-93.998-138.318-126.363
Other Financing Activities -25.7-36-3,894.918.046,979.46-663.9-997.05-2444.5805.4-159.53,630.9901.2-2,287.8605.1872,116.6382,287.611-1,111.1934,055.147-135.249
Financing Cash Flow -2.4-183.8-11,758.54-471.1907.39-1,011.4-1,643.48-842.5-1,173.8-7-302.61,049-1,336.3-670.6275.5911,599.1352,210.739-2,349.6653,813.101-351.887
Other Information:
Effect Of Forex Changes On Cash 0.0310.1-0.13-1.142.43-3.57000.100.21.13.6-1.7-7.72200.82631.31752.941.883
Net Change In Cash 996.28-105-17.29118.61257.52-19.7189.69-4.2-102.4-8.4-141.1197.9-290.931.1-282.232378.013-958.838975.7454,349.291-541.907
Cash At End Of Period 1,394.8398.5503.5520.79402.18144.66164.3793.197.5200208.4349.5151.7393.5395.815673.848295.8351,254.6734,448.9799.679